Literature DB >> 29238888

Synthesis and evaluation of bile acid amides of [Formula: see text]-cyanostilbenes as anticancer agents.

Devesh S Agarwal1, Rajnish Prakash Singh2, K Lohitesh2, Prabhat N Jha2, Rajdeep Chowdhury2, Rajeev Sakhuja3.   

Abstract

A series of amino-substituted [Formula: see text]-cyanostilbene derivatives and their bile acid (cholic and deoxycholic acid) amides were designed and synthesized. A comparative study on the anticancer and antibacterial activity evaluation on the synthesized analogs was carried against the human osteosarcoma (HOS) cancer cell line, and two gram -ve (E. coli and S. typhi) and two gram [Formula: see text]ve (B. subtilis and S. aureus) bacterial strains. All the cholic acid [Formula: see text]-cyanostilbene amides showed an [Formula: see text] in the range 2-13 [Formula: see text] against human osteosarcoma cells (HOS) with the most active analog (6g) possessing an [Formula: see text] of [Formula: see text]. One of the amino-substituted [Formula: see text]-cyanostilbene, 4e, was found to possess an [Formula: see text] of [Formula: see text]. An increase in the number of cells at the sub-[Formula: see text] phase of the cell was observed in the in vitro cell cycle analysis of two most active compounds in the series (4e, 6g) suggesting a clear indication toward induction of apoptotic cascade. With respect to antibacterial screening, amino-substituted [Formula: see text]-cyanostilbenes were found to be more active than their corresponding bile acid amides. The synthesized compounds were also subjected to in silico study to predict their physiochemical properties and drug-likeness score.

Entities:  

Keywords:  -cyanostilbene; Antibacterial; Anticancer; Bile acid; Cancer

Mesh:

Substances:

Year:  2017        PMID: 29238888     DOI: 10.1007/s11030-017-9797-9

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  33 in total

1.  Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linked via amino acids as anti-cancer agents.

Authors:  Devesh S Agarwal; Hasitha Shilpa Anantaraju; Dharmarajan Sriram; Perumal Yogeeswari; Shankara H Nanjegowda; P Mallu; Rajeev Sakhuja
Journal:  Steroids       Date:  2015-12-31       Impact factor: 2.668

2.  Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.

Authors:  Mohammad Sayed Alam; Young-Joo Nam; Dong-Ung Lee
Journal:  Eur J Med Chem       Date:  2013-09-19       Impact factor: 6.514

3.  Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines.

Authors:  Dominique Brossard; Laïla El Kihel; Monique Clément; Walae Sebbahi; Mohamed Khalid; Christos Roussakis; Sylvain Rault
Journal:  Eur J Med Chem       Date:  2010-03-19       Impact factor: 6.514

4.  Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.

Authors:  Celia Maria Freitas Gomes; Heidi van Paassen; Salvatore Romeo; Mick M Welling; R I J Feitsma; Antero J Abrunhosa; M Filomena Botelho; Pancras C W Hogendoorn; Ernest Pauwels; Anne Marie Cleton-Jansen
Journal:  Nucl Med Biol       Date:  2006-10       Impact factor: 2.408

5.  Increased acyclovir oral bioavailability via a bile acid conjugate.

Authors:  Sanna Tolle-Sander; Kimberley A Lentz; Dean Y Maeda; Andrew Coop; James E Polli
Journal:  Mol Pharm       Date:  2004-01-12       Impact factor: 4.939

6.  Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Authors:  David S Alberts; María Elena Martínez; Lisa M Hess; Janine G Einspahr; Sylvan B Green; A K Bhattacharyya; Jose Guillen; Mary Krutzsch; Ashok K Batta; Gerald Salen; Liane Fales; Kris Koonce; Dianne Parish; Mary Clouser; Denise Roe; Peter Lance
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

Review 7.  Evolving treatment of advanced colon cancer.

Authors:  Neil H Segal; Leonard B Saltz
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

8.  Ceragenins: cholic acid-based mimics of antimicrobial peptides.

Authors:  Xin-Zhong Lai; Yanshu Feng; Jacob Pollard; Judy N Chin; Michael J Rybak; Robert Bucki; Raquel F Epand; Richard M Epand; Paul B Savage
Journal:  Acc Chem Res       Date:  2008-07-11       Impact factor: 22.384

9.  Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.

Authors:  Norahayu Othman; Lionel L A In; Jennifer A Harikrishna; Noor Hasima
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  Synthesis, antiproliferative activity and molecular properties predictions of galloyl derivatives.

Authors:  Marciane Maximo da Silva; Marina Comin; Thiago Santos Duarte; Mary Ann Foglio; João Ernesto de Carvalho; Maria Carmo do Vieira; Anelise Samara Nazari Formagio
Journal:  Molecules       Date:  2015-03-25       Impact factor: 4.411

View more
  1 in total

Review 1.  Bile Acid Conjugates with Anticancer Activity: Most Recent Research.

Authors:  Maria Luisa Navacchia; Elena Marchesi; Daniela Perrone
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.